Edesa Biotech, Inc.
Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.
EDSA | NDAQ
Overview
Corporate Details
- ISIN(s):
- CA27966L1085 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 100 SPY COURT, 0 MARKHAM
- Website:
- https://www.edesabiotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes innovative treatments for inflammatory and immune-related diseases. The company focuses on creating novel, host-directed therapeutics as alternatives to conventional treatments like steroids and JAK inhibitors. Its clinical pipeline targets various acute and chronic conditions, with a significant program focused on Acute Respiratory Distress Syndrome (ARDS), a leading cause of mortality in intensive care units. Edesa is dedicated to advancing its portfolio of late-stage drug candidates to address unmet medical needs and improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Edesa Biotech, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Edesa Biotech, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Edesa Biotech, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
